(Q53590651)

16 May 2018

title

Comparison of the efficacy of rabeprazole 10 mg and omeprazole 20 mg for the healing rapidity of peptic ulcer diseases. (English)

1 reference

16 May 2018

0 references

1 reference

Sangwon Ji

1

1 reference

16 May 2018

Hyun Soo Kim

2

1 reference

16 May 2018

Jae Woo Kim

3

1 reference

16 May 2018

Myeong Kwan Jee

4

1 reference

16 May 2018

Kwang Wha Park

5

1 reference

16 May 2018

Young Uh

6

1 reference

16 May 2018

Dong Ki Lee

7

1 reference

16 May 2018

Jae Suk Song

8

1 reference

16 May 2018

Soon Koo Baik

9

1 reference

16 May 2018

Sang Ok Kwon

10

1 reference

16 May 2018

publication date

1 September 2006

1 reference

16 May 2018

Journal of Gastroenterology and Hepatology

published in

1 reference

16 May 2018

volume

21

1 reference

16 May 2018

page(s)

1381-1387

1 reference

16 May 2018

issue

9

1 reference

16 May 2018

The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+, K(+)-ATPase is correlatedwith the rate of acid-activation of the inhibitor

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer--a European multicentre study. The European Rabeprazole Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

The treatment of gastric ulcer with antisecretory drugs. Relationship of pharmacological effect to healing rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Pharmacokinetics and bioavailability of omeprazole after single and repeated oral administration in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Antibacterial treatment of gastric ulcers associated with Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Reliability of radiographic observations recorded on a proforma measured using inter- and intra-observer variation: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

CYP2C19 genotype status and effect of omeprazole on intragastric pH in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Rabeprazole produces rapid, potent, and long-acting inhibition of gastric acid secretion in subjects with Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Phenotyping polymorphic drug metabolism in the French Caucasian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2006.04314.X

10.1111/J.1440-1746.2006.04314.X

21 January 2018

Identifiers

DOI

1 reference

16 May 2018

release_paqozs5lgvb5voz5rs67hmcxhy

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/paqozs5lgvb5voz5rs67hmcxhy

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16911680

1 reference

16 May 2018